Marker Therapeutics, Inc.·4

Nov 29, 4:05 PM ET

Kim Anthony H. 4

4 · Marker Therapeutics, Inc. · Filed Nov 29, 2018

Insider Transaction Report

Form 4
Period: 2018-11-27
Kim Anthony H.
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2018-11-27+400,000400,000 total
    Exercise: $6.81Exp: 2028-11-27Common Stock (400,000 underlying)
Footnotes (1)
  • [F1]Represents options granted under the Company's 2014 Omnibus Stock Ownership Plan, as amended, in connection with the execution of an employment agreement with the Company. One quarter of the shares vest on the first anniversary of the grant date and the remainder of the shares subsequently vest in equal monthly installments over a three year period upon the continued employment by the Company of the Reporting Person through the vesting dates. The option exercise price is the closing price on the date of the grant, November 27, 2018.

Documents

1 file
  • 4
    tv508156_4.xmlPrimary

    OWNERSHIP DOCUMENT